Evidence map›Paper›PMID 24982315›Full record

ReviewClinical microbiology reviews2014

Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Yvonne Achermann, Ellie J C Goldstein, Tom Coenye, Mark E Shirtliff

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 302 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
302citing papers in PubMed, 5 pooled it
31.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03450369 phase1completednot on this mapstarted 2018, after this paper: background citation

A Phase 1B Dose Escalating Study of the Safety, Short-Term Engraftment and Action of a Singly-Applied NB01 in Adults With Moderate Acne

TypeinterventionalSponsorNaked Biome, Inc.Ran2018 to 2018Enrolled10ConditionsAcne VulgarisArmsNB01
NCT03853096 early_phase1unknown statusnot on this mapstarted 2019, after this paper: background citation

Do Intra-incisional Subdermal Antibiotics Alter the Colony Count of P. Acnes

TypeinterventionalSponsorUniversity of British ColumbiaRan2019 to 2020Enrolled20ConditionsSurgical Site Infection, Microbial ColonizationArmsCefazolin
3 · Its place in the literature

Who cites it

302 citing papers in PubMed, 5 syntheses or guidelines pooled it, 610 citations in OpenAlex.

  1. Antibiotic resistance rates inFrontiers in microbiology · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Evidence for infection in intervertebral disc degeneration: a systematic review.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2022
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. IntradiscalInternational journal of spine surgery · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. JSES reviews, reports, and techniques · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

242 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Yvonne AchermannDepartment of Microbial Pathogenesis, Dental School, University of Maryland, Baltimore, Maryland, USA.
Ellie J C GoldsteinR. M. Alden Research Laboratory, Santa Monica, CA, USA, and David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Tom CoenyeLaboratorium voor Farmaceutische Microbiologie, Ghent University, Ghent, Belgium.
Mark E ShirtliffDepartment of Microbial Pathogenesis, Dental School, University of Maryland, Baltimore, Maryland, USA Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, USA mshirtliff@umaryland.edu.
University of Maryland, Baltimore · USGhent University · BEUniversity of California, Los Angeles · US

Funding

Staphylococcus aureus biofilms: in vitro and in vivo studiesR01AI069568 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SHIRTLIFF, MARK E · 2007 to 2011
$2.1M
NIAID NIH HHS R01 AI069568NIAID NIH HHS R01 AI69568-01A2
6 · The paper itself

Abstract

Propionibacterium acnes is known primarily as a skin commensal. However, it can present as an opportunistic pathogen via bacterial seeding to cause invasive infections such as implant-associated infections. These infections have gained more attention due to improved diagnostic procedures, such as sonication of explanted foreign materials and prolonged cultivation time of up to 14 days for periprosthetic biopsy specimens, and improved molecular methods, such as broad-range 16S rRNA gene PCR. Implant-associated infections caused by P. acnes are most often described for shoulder prosthetic joint infections as well as cerebrovascular shunt infections, fibrosis of breast implants, and infections of cardiovascular devices. P. acnes causes disease through a number of virulence factors, such as biofilm formation. P. acnes is highly susceptible to a wide range of antibiotics, including beta-lactams, quinolones, clindamycin, and rifampin, although resistance to clindamycin is increasing. Treatment requires a combination of surgery and a prolonged antibiotic treatment regimen to successfully eliminate the remaining bacteria. Most authors suggest a course of 3 to 6 months of antibiotic treatment, including 2 to 6 weeks of intravenous treatment with a beta-lactam. While recently reported data showed a good efficacy of rifampin against P. acnes biofilms, prospective, randomized, controlled studies are needed to confirm evidence for combination treatment with rifampin, as has been performed for staphylococcal implant-associated infections.

Indexed as

AnimalsBiofilmsGram-Positive Bacterial InfectionsHost-Pathogen InteractionsHumansMetagenomeMicrobiotaPropionibacterium acnesProstheses and ImplantsProsthesis-Related InfectionsVirulence

Identifiers

PMID24982315
PMCPMC4135900
OpenAlexW1969968936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.